BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Citi maintains buy on Biocon
Citi has maintained its "buy" call on Biocon for a target price of Rs 1,170. Biocon remains India's most leveraged play. We value the base business of Biocon at 20 times its FY2018 estimated EPS.